Clinical Trial Update: An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated the effectiveness and safety of Depakote ER (divalproex sodium extended-release) for mania in bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Abbott | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED